Gelibolu Tuzlu Sardalyasının +4oC de Raf Ömrünün Belirlenmesi
نویسندگان
چکیده
منابع مشابه
Kamu İnternet Sitelerinde Yer Alan Arama Alanlarının Kullanılabilirliğinin Belirlenmesi
Özet. Kamu kurumlarının sahip olduğu internet sayfaları ilgili kamu kurumunun sunduğu hizmetlerden yararlanan tüm vatandaşlar tarafından kullanılmaktadır. Kamu kurumlarının internet sitelerinin kullanılabilirliğinden kaynaklanan sorunlar, büyük verimlilik kayıplarına neden olmakta ve vatandaşların aldıkları hizmetin kalitesini düşürmektedir. Bu çalışmada Türkiye’de bulunan 21 Bakanlık internet ...
متن کاملKlinik Olarak Anaplasmosis Şüphesi Olan Ruminantlarda cELISA’nın Tanısal Değerinin Belirlenmesi
The aim of this study was to determine diagnostic value of cELISA in anaplasmosis in clinically suspected animals and to compare the cELISA results with the clinical examination results. For this purpose a total of 720 ruminants (457 cattle, 146 sheep, 117 goat) were examined in terms of clinical signs. Eighty-eight ruminants consisting of 61 cattle, 11 sheep and 16 goat which had the symptoms ...
متن کاملRaf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.
Raf kinase inhibitory protein (RKIP; also known as phosphatidylethanolamine-binding protein or PEBP) is a modulator of the Raf/MAPK signaling cascade and a suppressor of metastatic cancer. Here, we show that RKIP inhibits MAPK by regulating Raf-1 activation; specifically, RKIP acts subsequent to Raf-1 membrane recruitment, prevents association of Raf-1 and p21-activated kinase (PAK), and blocks...
متن کاملC-RAF mutations confer resistance to RAF inhibitors.
Melanomas that contain B-RAF(V600E) mutations respond transiently to RAF and MEK inhibitors; however, resistance to these agents remains a formidable challenge. Although B- or C-RAF dysregulation represents prominent resistance mechanisms, resistance-associated point mutations in RAF oncoproteins are surprisingly rare. To gain insights herein, we conducted random mutagenesis screens to identify...
متن کاملThe Brothers RAF
Targeted molecular therapies for cancer treatment have shown promise, but also have limitations. In this issue, Heidorn et al. (2010) find that a class of targeted molecular therapies with clinical effectiveness against one melanoma subtype may have adverse clinical effects in another.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ÇOMÜ Ziraat Fakültesi Dergisi
سال: 2018
ISSN: 2147-8384
DOI: 10.33202/comuagri.504295